Call for Integration of Screening of Other Respiratory Diseases of Epidemic Potential in TB Traditional Clinics

Main Article Content

Thomas Nyirenda Soo Young Moon Sungjung Jang Jonathan Choe Sung-Hyeon Yu Dowon Chung Richard Kang George Mwenye-Phiri Louis Mnyema Ng’oma Elled Mwenyekonde Adriano Focus Lubanga

Abstract

Introduction: Medical advances in the last six decades have made tuberculosis (TB) a curable disease. We conducted a Systematic Literature Review to examine the potential impact of the COVID-19 pandemic on TB programmes.


Methods: We conducted a Systematic Literature Review to examine the potential impact of the COVID-19 pandemic on TB programmes. We searched online publication databases and World Health Organisation publications on the interaction of TB and COVID-19 pandemic.


Results: Our survey shows that during the period of the pandemic the world saw reversal of gains following the disruption of TB programmes. This was due to applied lockdowns and reduced financing to the programmes. During the years of the pandemic (2020 to 2021) both diseases killed comparably close to 1.5 million people each. Justifiably, priority was given to dealing with the COVID-19 pandemic whose epidemiology was poorly understood. Global funding to TB control reduced while a record level of global resources ever to be allocated to one disease in a space of two years was amassed to fighting the COVID-19 pandemic.


Conclusion: Available evidence in literature show considerable disruption of well-running TB programmes when the world was affected by the pandemic. To avoid repeating similar mistakes when the world experiences another COVID-like pandemic we strongly advocate for integrating TB and Severe Acute Respiratory Syndrome-related Coronaviruses (SARSr-CoV) control programmes. This is justifiable from many reasons including the observations that both diseases 1) affect the lungs and can worsen the treatment outcomes of each other, 2) are biggest killers among unvaccinated individuals, 3) carry a similarly high very level of stigma within communities, and 4) need adequate funding to control. In addition, SARSr-CoV prevention and control can benefit from longstanding structures and patient management methods that have been built to fight TB and vice versa.

Article Details

How to Cite
NYIRENDA, Thomas et al. Call for Integration of Screening of Other Respiratory Diseases of Epidemic Potential in TB Traditional Clinics. Medical Research Archives, [S.l.], v. 11, n. 5, may 2023. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/3695>. Date accessed: 03 oct. 2024. doi: https://doi.org/10.18103/mra.v11i5.3695.
Section
Research Articles

References

1. Barry R Bloom, Rifat Atun, Ted Cohen, Christopher Dye, Hamish Fraser, Gabriela B Gomez, Gwen, knight, Megan Murray, Edward Nardell, Eric, Rubin, Joshua Salomon, Anna Vassall, Grigory Volchenkov, Richard White, Douglas Wilson, Prashant Yadav, King K Holmes, Stefano Bertozzi, Barry R Bloom, Prabhat Jha. Tuberculosis. In: Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. DOI: 10.1596/978-1-4648-0524-0_ch11
2. https://who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022/tb-disease-burden
3. Anastasia Koch and Valerie Mizrahi . Mycobacterium tuberculosis. Trends Microbiol. 2018 Jun;26(6):555-556. doi: 10.1016/j.tim.2018.02.012. Epub 2018 Mar 23
4. Jeffrey A Tornheim, Kelly E Dooley. Challenges of TB and HIV co-treatment: updates and insights. Curr Opin HIV AIDS. 2018 Nov; 13(6): 486-491. doi:10.1097/COH.0000000000000495.
5. Kwonjune J Seung, Salmaan Keshavjee, Michael L Rich. Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med. 2015 Apr 27;5(9):a017863. doi: 10.1101/cshperspect.a017863.
6. S N Mehta, M Murrill, N Suryavanshi, R Bhosale, S Naik, N Patil, A Gupta, J Mathad, R Shivakoti, M Alexander. TB-related knowledge and stigma among pregnant women in low-resource settings. Int J Tuberc Lung Dis. 2021 Feb 1;25(2):148-150. doi: 10.5588/ijtld.20.0241.
7. World health organization, (2022, January 17). A report about Coronavirus. Retrieved from https://covid19.who.int/
8. D Visca, C W M Ong, S Tiberi, R Centis, L D'Ambrosio, B Chen, J Mueller, P Mueller, R Duarte, M Dalcolmo, G Sotgiu, G B Migliori, D Goletti. Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology. 2021 Mar-Apr;27(2):151-165. doi: 10.1016/j.pulmoe.2020.12.012. Epub 2021 Jan 22.
9. Mariana Marti, Kathrin Zürcher, Leslie A Enane, Lameck Diero, Olivier Marcy, Thierry Tiendrebeogo, Marcel Yotebieng, Christelle Twizere, Suwimon Khusuwan, Evy Yunihastuti, Gary Reubenson, N Sarita Shah, Matthias Egger, Marie Ballif, Lukas Fenner. IeDEA global consortium. Impact of the COVID-19 pandemic on TB services at ART programmes in low- and middle-income countries: a multi-cohort survey. J Int AIDS Soc. 2022 Oct;25(10):e26018. doi: 10.1002/jia2.26018.
10. https://w.worldometers.info/world-population/africa-population/#:~:text=The%20current%20population%20of%20Africa,of%20the%20total%20world%20population.
11. https://www.lshtm.ac.uk/research/centres/health-humanitarian-crises-centre/news/343596/will-war-ukraine-lead-spike-tuberculosis-cases.

Most read articles by the same author(s)